While Americans squabble over irrelevant political diversions, a revolutionary breakthrough in human healthcare has yielded its first FDA approval – a therapy that literally cures otherwise incurable leukemia.
It is the first of many therapies that re-engineer human cells in living patients to reprogram more resilient immune systems and even repair damaged or aging organs.
What would seem like headline news has instead squeaked through as a whimper – not because it is insignificant – but because of how this monumental breakthrough has been hijacked by special interests and how these interests plan on making Americans pay twice for its development behind a smokescreen of public ignorance.
Thanks to a media focused more on dividing and distracting Americans regarding irrelevant political charades, due diligence in researching the story was either sidestepped intentionally, or a result of unprofessional and incompetent journalism.
Taxpayers and Charity Paid First
For the past 20 years, American taxpayers through the National Institutes of Health (NIH) and the Leukemia & Lymphoma Society (LLS) helped fund a revolutionary cancer treatment that sidesteps devastating and ineffective chemotherapy and instead, re-engineers a patient’s own immune system to find and destroy tumors.
Source: Curing Incurable Leukemia
